NEWTOWN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and ...
Medtronic plc (NYSE: MDT), a global healthcare technology leader, today announced its intent to acquire SPR Therapeutics, Inc. (SPR), a privately held medical technology company and a recognized ...
Medtronic will acquire SPR Therapeutics for $650 million, adding the FDA-cleared SPRINT PNS System for temporary PNS to its ...
Experts are already treating addicted people with at-home neuromodulation devices to control cravings, and the future is ...
The FDA authorized marketing of the Portable Neuromodulation Stimulator (Pons) for short-term treatment of gait issues arising from mild to moderate symptoms associated with multiple sclerosis (MS) ...
Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to ...
Could a new device called a portable neuromodulation stimulator (PoNS) help improve your mobility and balance with multiple sclerosis? PoNS is a device that delivers mild electrical pulses to two ...
HOUSTON--(BUSINESS WIRE)--Motif Neurotech, a neurotechnology company developing minimally invasive bioelectronics for mental health, announced today new research published to the preprint server ...
—–In an interview with MedPage Today, Dr. Kapoor, from the Department of Pain Management at Cleveland Clinic, discusses the role of implantation of a permanent neuromodulation device in management of ...
NEWTOWN, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results